Lawit, Edilberto N.

HRN: 23-62-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2023
CEFTRIAXONE 1G (VIAL)
08/30/2023
09/06/2023
IV
2grams
Once Daily
Empiric
Waiting Final Action 
08/30/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/30/2023
09/06/2023
IV
500mg
Every 8hours
Empiric
Waiting Final Action 
09/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/01/2023
09/08/2023
IVT
4.5gms
Q8
S/p Exlap Ap
Waiting Final Action 
09/05/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/05/2023
09/08/2023
IV
4.5grams
Q 8hrs
S/p Exlap Appendectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: